目的评估伊曲康唑注射液治疗侵袭性真菌感染的肝脏安全性。
Objective To investigate the hepatic safety of itraconazole intravenous solution in the treatment of invasive fungal infection.
目的研究伊曲康唑治疗恶性血液病合并侵袭性真菌感染的疗效。
Objective to investigate the efficacy of itraconazole in the treatment of malignant hematological diseases with invasive fungal infections.
目的：探讨伏立康唑治疗恶性血液病患者合并侵袭性真菌感染的结果。
Objective:To investigate the effects of voriconazole in patients with malignant hematological disorders complicated by invasive fungal infection.
泊沙康唑为一新型三唑类抗真菌药，用于治疗和预防侵袭性真菌感染。
Posaconazale is a new triazole drug for the treatment and prevention of invasive fungal infections.
结论：伊曲康唑治疗肺部侵袭性真菌感染疗效确切，副作用小，值得推广使用。
Conclusion: Itraconazole treatment of pulmonary invasive fungal infections is effective, side-effect is small, it should be promoted.
侵袭性真菌感染(ifi)是导致恶性血液病患者发病和死亡的重要原因之一。
Invasive fungal infection (ifi) is associated with significant morbidity and mortality in patients with hematologic malignancies.
评估伊曲康唑治疗ICU中危重患者侵袭性真菌感染（IFI）的疗效及安全性。
To evaluate the efficacy and safety of itraconazloe in treating the invasive fugal infection(IFI) in ICU.
棘球白素在选择侵袭性真菌感染，最显着的侵袭性念珠菌和曲霉病的治疗已经取得了显着的影响。
Echinocandins have made a significant impact in the treatment of select invasive fungal infections, most notably invasive candidiasis and aspergillosis.
侵袭性真菌感染，尤其是念珠菌血症和系统性念珠菌病，在过去几十年已成为发病率和死亡率的主要原因。
Invasive fungal infections, especially candidemia and systemic candidiasis, have become a major cause of morbidity and mortality in the last few decades.
近来，由于多种抗真菌药物的问世，IDSA的指南出现了一些显著变化，尤其是针对侵袭性真菌感染的治疗。
Recently, there have been several significant changes in IDSA guidelines especially in the treatment of invasive fungal infection because of developments in several antifungal agents.
侵袭性真菌感染(ifi)是一种十分严重的造血干细胞移植(HSCT)并发症，以念珠菌属和曲霉菌属感染最常见。
Invasive fungal infections (IFI) are a kind of the most severe complications after hematopoietic stem cell transplantation (HSCT), Candida and Aspergillus are common causes.
侵袭性真菌感染(ifi)是恶性血液病、长时间中性粒细胞减少或造血干细胞移植后患者重要的发病和死亡原因之一。
Invasive fungal infection (IFI) is an important cause of morbidity and mortality in patients with hematologic malignancy, prolonged neutropenia, or after hematopoietic stem cell transplant.
泊沙康唑在体外具有广谱抗真菌活性，对于高危hsct受者以及持续中性粒细胞减少患者侵袭性真菌感染的预防可能有重要作用。
Posaconazole has a broad spectrum of activity in vitro and a potentially key role in antifungal prophylaxis in high-risk HSCT recipients and during prolonged neutropenia.
这两种感染都是严重威胁生命的疾病，尤其对于免疫功能抑制的患者，侵袭性真菌疾病所致的死亡率常超过30%。
Infection with either can lead to severe life-threatening disease, particularly in immunosuppressed patients, with mortality rates for invasive fungal disease often exceeding 30%.
病情危重，长期应用抗生素、激素及侵袭性操作均是真菌感染的因素。
The factors related to nosocomial fungal infection were the severity of the primary disease, long-term use of antibiotics and glucocorticoid, invasive procedure.
分析临床上侵袭性肺部真菌感染的诊断及治疗情况；
To evaluate the status of the diagnosis and treatment of invasive pulmonary fungal infections;
分析临床上侵袭性肺部真菌感染的诊断及治疗情况；
To evaluate the status of the diagnosis and treatment of invasive pulmonary fungal infections;
应用推荐